Skip to content

Radon Asthma Intervention Trial

Radon Asthma Intervention Trial

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06706336
Acronym
ROME
Enrollment
180
Registered
2024-11-26
Start date
2026-06-01
Completion date
2030-04-01
Last updated
2026-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Brief summary

To determine if radon mitigation can improve asthma

Detailed description

We will conduct a randomized, double-blind, sham controlled trial to investigate the efficacy of radon mitigation in the homes of susceptible individuals to provide evidence for health benefits by improving indoor air quality. The trial will include 180 children with asthma. We will install a standard radon specific mitigation system in the participant's home. Health outcomes will be followed over 48 weeks to determine the outcomes of the intervention versus inactive (sham) control.

Interventions

OTHERradon mitigation system

standard radon mitigation system used to reduce radon in homes

OTHERSham (No Treatment)

inactive radon mitigation system

Sponsors

Boston Children's Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
5 Years to 25 Years
Healthy volunteers
No

Inclusion criteria

1. Have physician-diagnosed asthma at least 1 year prior to the screening visit 2. Have evidence of uncontrolled disease as defined by at least one of the following: Use of an asthma medication during the prior 12 months, report of asthma symptoms over the prior 12 months (wheezing/whistling in the chest)(3) OR One or more asthma-related hospitalization, emergency room visit OR Unscheduled clinic or urgent care facility visit resulting in a burst of systemic steroids (3 days or more of prednisone or equivalent; 1 or more doses of dexamethasone) in the previous 12 months

Exclusion criteria

1. Not residing at the household for at least 5 days a week or family planning to move from the current home within the next twelve months, or homes with active radon mitigation systems (if home uses a HEPA filter air purifier, family must agree to disable the purifier for 28 days prior to randomization). 2. Lung disease, other than asthma, that requires daily medication (inflammatory diseases, chronic lung diseases aside from asthma, congenital cardiopulmonary conditions requiring medication or surgical treatment), 3. Homes with active HEPA filters will be excluded (even though the role of HEPA filters on radon and radon particles s is expected to be minimum and other exposures can be adjust for in the analysis) 4. Cardiovascular disease that requires daily medication, excluding hypertension 5. Taking a beta-blocker 6. Currently receiving unstable level of Immunotherapy (allergy shots) 7. Coordinator/PI judgment 8. Inability to perform lung function testing 9. Intake of abuse drugs or alcohol, have psychiatric disorders or severe mental disability that interferes with answering questions or following instructions.

Design outcomes

Primary

MeasureTime frameDescription
Asthma symptomspast 2 weeksNumber of Days With Asthma Symptoms

Contacts

CONTACTWanda Phipatanakul
Asthma@childrens.harvard.edu857-218-5336
PRINCIPAL_INVESTIGATORWanda Phipatanakul

Boston Children's Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026